肝细胞癌长程化管理的思考与实践

Reflection and practice of long-term management of hepatocellular carcinoma

  • 摘要: 肝细胞癌(以下简称肝癌)的治疗一直是全世界范围内不断探索的医学热点。目前,多采用以手术切除为主,介入、化疗及放疗等为辅的综合诊断与治疗策略。近年来,尽管肝癌的总体生存时间得到显著延长,然而,其整体诊断与治疗效果仍不尽人意。系统性治疗新药的不断涌现并应用于临床,为肝癌的治疗带来新机遇和挑战。但是,过多的诊断与治疗主体导致现有分科体制与实现有序且规范的肝癌治疗之间的矛盾显得尤为突出,未来如何实现统一且规范的同质化诊断与治疗是亟待解决的关键问题。笔者结合自身的临床经验,梳理国内外肝癌研究的最新进展,阐述当前肝癌的诊断与治疗现状,提出肝癌长程化管理理念,并通过构建肝胆外科肝癌综合技术诊断与治疗团队,对肝癌患者的综合诊断与治疗进行新实践和探索。

     

    Abstract: The treatment of hepatocellular carcinoma (HCC) has always been a hot spot of medical research worldwide. At present, surgical resection is the main therapy for HCC, supplemen-ted by interventional therapy, chemotherapy, radiotherapy, etc. Although the overall survival of HCC has been significantly improved in recent years, the overall effect is still unsatisfactory. New systemic therapeutic drugs are constantly emerging and applied to clinical practice, which bring new opportunities and challenges for the treatment of HCC. However, too many diagnosis and treatment topics bring obvious contradiction between the division system and the orderly and standardized HCC treatment. In the future, how to realize unified and standardized homogeneous diagnosis and treatment is the key problem to be solved urgently. The authors summarize the current status of diagnosis and treatment of HCC and propose the long-term management concept for HCC according to their own clinical experience and the current advances of the diagnosis and treatment at home and abroad, and carry out new practice and investigation on the patients with HCC by constructing a hepatobiliary multi-technical team.

     

/

返回文章
返回